Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion-Reference-Cited by-同舟云学术

Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion

Published:2020-11-26 Issue:6 Volume:98 Page:405-413
ISSN:2412-1339
Container-title:Clinical Medicine (Russian Journal)
language:
Short-container-title:jour

Author:

Bokarev I. N.¹^ORCID,Popova L. V.²^ORCID

Affiliation:

1. Russian Association for the Study of Thrombosis, Hemorrhages and Vascular Pathology named after A.A. Schmidt–B.A. Kudryashova

2. Russian Association for the Study of Thrombosis, Hemorrhages and Vascular Pathology named after A.A. Schmidt–B.A. Kudryashova; First Moscow State Medical University of the Ministry of Health of the Russian Federation named after Sechenov I.M. (Sechenov University)

Abstract

The article provides an overview of the recent literature on the state of hemocoagulation in the viral disease COVID-19 caused by SARS-CoV-2. The issues of its pathogenesis are considered and assumptions are made about the possible benefits of patients from the use of medications that aﬀect the platelet units.

Publisher

Medical Informational Agency Publishers

Subject

General Medicine

Reference71 articles.

1. Worldometers. [Electronic resource]. URL: https://www.worldometers.info/coronavirus/ (5 jule 2020).

2. Robb J.A., Bond C.W. Coronaviridae. Comprehensive Virology. 1979;6:193–247. DOI: 10.1007/978-1-4684-3563-4_3.

3. Communicable disease threats report, 9–15 February 2020, week 7. ECDC (5 jule 2020) [Electronic resource]. URL: https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-15-Feb-2020-PUBLIC.pdf.

4. International Committee on Taxonomy of Viruses ICTV [Electronic resource]. URL: https://talk.ictvonline.org/ (5 june 2020).